Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2012
07/26/2012US20120187392 Imidazopyridine derivatives and organic electroluminescent elements containing same
07/26/2012US20120186648 Coaxial molecular stack for transferring photocurrent generation
07/26/2012CA2825367A1 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
07/26/2012CA2824873A1 Bicyclic carboxamide inhibitors of kinases
07/26/2012CA2824871A1 Bicyclic inhibitors of alk
07/26/2012CA2824460A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
07/26/2012CA2824332A1 Bicyclic inhibitors of alk
07/26/2012CA2823780A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
07/25/2012EP2477990A1 5-phenyl pyrazolopyridine derivatives, preparation and therapeutic use thereof
07/25/2012EP2477989A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY
07/25/2012EP2477988A1 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
07/25/2012EP2477987A1 Modulators of toll-like receptors
07/25/2012EP2477986A1 Phenanthroline derivatives and their use as ligands
07/25/2012EP2477985A1 Treatment of cancer
07/25/2012EP2477966A1 Processes and intermediates
07/25/2012EP2205558B1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators
07/25/2012EP2197844B1 Spiroheterocyclic pyrrolidine dione derivatives useful as pesticides
07/25/2012EP1954290B1 Tricyclic compounds useful as inhibitors of kinases
07/25/2012EP1706403B9 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
07/25/2012EP1252162B1 Alpha v integrin receptor antagonists
07/25/2012CN102612518A Nitrogen-containing condensed heterocyclic compounds for oleds
07/25/2012CN102604412A Bis-carbazole group containing dye for dye-sensitized solar cells and preparation method of bis-carbazole group containing dye
07/25/2012CN102603744A Sophocarpidine compound, preparation method thereof and disinfectant
07/25/2012CN102603743A Anti-tumor benzazepine[f]azulene derivative, preparation method thereof, and purpose thereof
07/25/2012CN102603742A Extraction method for bufothionine
07/25/2012CN102603741A 2,3,6,7-tetrabromonaphthalene tetracarboxylic acid imidodicarbonic diamide compound, manufacturing method and application of 2,3,6,7-tetrabromonaphthalene tetracarboxylic acid imidodicarbonic diamide compound
07/25/2012CN102603740A Synthetic method of 4-nitro-7-azaindole
07/25/2012CN102603739A Method for preparing compound, i.e., 2-(imidazo[1,2-alpha]pyridine-3-radical)acetic acid
07/25/2012CN102603738A Stable moxifloxacin hydrochloride compound
07/25/2012CN102603737A Pyridopyrimidine ketones derivative and application in preparing antitumor drugs thereof
07/25/2012CN102603736A Preparation method of (S,S)-2, 8-diazabicyclo[4,3,0] nonane
07/25/2012CN102603735A Preparation method of C-2 arylation indolizine compound
07/25/2012CN102603734A Protein kinase inhibitor and application thereof
07/25/2012CN102603733A 3, 8-bis-(5-methyl-2-thienyl)-1, 10-phenanthroline, preparation method thereof and application in zinc ion fluorescent sensing and cell imaging
07/25/2012CN102603732A Preparation method of dehydro-harmine
07/25/2012CN102603731A New quinolone derivative
07/25/2012CN102603688A 电致发光器件 Electroluminescent devices
07/25/2012CN102603581A Pyrrolo[2,3-b] pyridine derivatives as protein kinase inhibitors
07/25/2012CN102225937B Antineoplastic alkaloid compound, and its medicine composition, preparation method and application
07/25/2012CN101948471B Refining process of tosufloxacin tosylate
07/24/2012US8227603 Modulating skeletal muscle
07/24/2012US8227598 Heteroaryl carboxamides
07/24/2012US8227504 Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof
07/24/2012CA2690483C The use of anti-histaminics for acute reduction of elevated intracranial pressure
07/24/2012CA2517427C Antiprotozoal imidazopyridine compounds
07/24/2012CA2476065C Inhibitors of histone deacetylase
07/24/2012CA2412172C 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
07/19/2012WO2012097039A1 Imidazo [4, 5 -c] quinolin- 2 -one compound and its use as pi3 kinase / mtor dual inhibitor
07/19/2012WO2012096929A2 Heteroaryl compounds and methods of use thereof
07/19/2012WO2012096832A2 Hdac inhibiting derivatives of camptothecin
07/19/2012WO2012095790A1 Thiocyanato or isothiocyanato substituted naphthalene diimide and rylene diimide compounds and their use as n-type semiconductors
07/19/2012WO2012095463A1 Oxazine derivatives and their use in the treatment of neurological disorders
07/19/2012WO2011159917A3 Growth hormone secretatogue receptor antagonists and uses thereof
07/19/2012US20120184734 Substituted polycyclic carbamoylpyridone derivative
07/19/2012US20120184577 PI3 KINASE/mTOR DUAL INHIBITOR
07/19/2012US20120184562 1,6- and 1,8-naphthyridines
07/19/2012US20120184561 Phenylacetamides suitable as protein kinase inhibitors
07/19/2012US20120184556 Substituted enzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators
07/19/2012US20120184542 Pyrido pyrimidines
07/19/2012US20120184534 Tri-cyclic pyrazolopyridine kinase inhibitors
07/19/2012US20120184530 Dimeric IAP Inhibitors
07/19/2012US20120184528 7-ARYL-1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
07/19/2012US20120184527 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
07/19/2012US20120184526 Compounds and compositions as syk kinase inhibitors
07/19/2012US20120184525 1,2,3-triazolo [4,3-a] pyridine derivatives and thier use for the treatment of prevention of neurological and psychiatric disorders
07/19/2012US20120184524 Pyrazolopyridine kinase inhibitors
07/19/2012US20120183577 Compositions useful as inhibitors of protein kinases
07/19/2012US20120183563 Iminothiadiazine dioxide compounds as bace inhibitors, compositions and their use
07/19/2012US20120183522 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
07/19/2012US20120183496 Inhibitors of hepatitis c virus polymerase
07/19/2012CA2824760A1 Imidazo [4, 5 -c] quinolin- 2 -one compound and its use as pi3 kinase / mtor dual inhibitor
07/19/2012CA2824097A1 Oxazine derivatives and their use in the treatment of neurological disorders
07/19/2012CA2824047A1 Heteroaryl compounds and methods of use thereof
07/18/2012EP2476738A2 New heterocyclic derivative and organic light emitting device using same
07/18/2012EP2476681A2 Amino-aza-adamantane derivatives and methods of use
07/18/2012EP2476680A1 (1-Azinone)-Substituted Pyridoindoles
07/18/2012EP2476679A2 Substituted triazoles useful as AXL inhibitors
07/18/2012EP2476678A1 Substituted carbonyl compounds
07/18/2012EP2475664A2 Histamine h3 inverse agonists and antagonists and methods of use thereof
07/18/2012EP2475663A2 Paliperidone or a pharmaceutically acceptable salt thereof substantially free of impurities
07/18/2012EP2475662A2 Histamine h3 inverse agonists and antagonists and methods of use thereof
07/18/2012EP2475661A1 Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer
07/18/2012EP2475660A1 Pyrrolo-pyridine derivatives as activators of ampk
07/18/2012EP2475659A1 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
07/18/2012EP2475428A1 Heterocylcic derivatives as inhibitors of glutaminyl cyclase
07/18/2012EP2475256A1 Hepatitis c virus inhibitors
07/18/2012EP2475254A1 Hepatitis c virus inhibitors
07/18/2012EP2296651B1 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases
07/18/2012EP1608648B1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
07/18/2012CN1951917B Pyridinone derivatives for treatment of atherosclerosis
07/18/2012CN102596955A Histamine H3 inverse agonists and antagonists and methods of use thereof
07/18/2012CN102596954A JAK2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
07/18/2012CN102596953A Propane-i-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof
07/18/2012CN102596952A Pyrroloquinoline quinone in free form
07/18/2012CN102596951A Heterocyclic sulfonamide derivatives useful as mek inhibitors
07/18/2012CN102596202A New crystalline form of pemirolast
07/18/2012CN102596200A Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
07/18/2012CN102584863A Metal complex of novel double piperidine derivative with symmetric structure
07/18/2012CN102584830A Dihydroindene amide compounds, and medicinal composition and application thereof
07/18/2012CN102584824A Method for extracting voacangine
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 646